Two phase I studies of recombinant human IL-15 in combination with haploidentical NK cell infusions for solid tumors and AML showed improvements in in vivo expansion compared to historical reports of IL-2 mediated expansion [118]. The gene discussed is IL15; the disease is acute myeloid leukemia.